P3 Health Partners (PIII)
Nasdaq Market Closed
P3 Health Partners Inc. is a healthcare services company that specializes in population health management, with a model built around value-based care. Rather than operating as a traditional fee-for-service provider, P3 works with physicians, health plans, and community healthcare resources to coordinate care for patient populations, particularly in arrangements where outcomes, quality measures, and total cost of care are financially important.
The company’s approach is physician-led and patient-centered. It seeks to connect primary care doctors, specialists, hospitals, and other local providers into networks that can manage patients more proactively. This includes identifying care gaps, supporting chronic disease management, improving access to preventive services, and helping physicians use data and care coordination tools to make better clinical decisions. The aim is to improve patient outcomes while reducing avoidable medical spending, such as unnecessary emergency room visits or hospital admissions.
P3’s business fits within a broader shift in the US healthcare system toward risk-based and value-based reimbursement. In these models, providers and care-management organizations may benefit when they deliver high-quality care more efficiently, but they also assume greater responsibility for medical cost trends. That makes operational execution, provider engagement, accurate risk adjustment, and disciplined patient management central to the company’s performance.
For investors, P3 Health Partners represents exposure to the evolving managed care and healthcare delivery market. Its prospects depend on expanding provider networks, maintaining payer relationships, improving clinical and financial outcomes, and scaling its model while navigating reimbursement rules, healthcare regulation, and the complexity of caring for higher-need patient populations.
Last updated
- Market Cap
- 33.42M
- P/E
- —
- P/FCF
- —
- P/S
- 0.02
- Enterprise Value
- 319.77M
- Sector
- —
- Industry
- —
- Address
- 2045 W GRAND AVE STE B, CHICAGO, IL, 60612-1577
Wolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.
Kuehn Law Encourages Investors of P3 Health Partners Inc. to Contact Law Firm
P3 Health Partners: Moving In The Right Direction In 2024
P3 Health Partners Inc. (PIII) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
Here's Why P3 Health Partners Inc. (PIII) is Poised for a Turnaround After Losing -28.57% in 4 Weeks
Here Is Why Bargain Hunters Would Love Fast-paced Mover P3 Health Partners Inc. (PIII)
P3 Health Partners Provides Second-Quarter and Year-to-Date 2022 Financial Results; Increases 2022 Revenue Outlook
P3 Health Partners Announces Chief Financial Officer Transition Appoints Erin Darakjian as Interim CFO
P3 Health Partners Fireside Chat Hosted by LifeSci Advisors, LLC
P3 Health Partners CEO Dr. Sherif Abdou Featured on Benchtop Bios Podcast
P3 Health Partners Announces Receipt of Nasdaq Notice Regarding Late Filing of Periodic Report
Oregon State Athletics, P3 Health Partners Oregon Announce Multi-Year Relationship
P3 Health Partners Announces Receipt of Nasdaq Notice Regarding Late Filing of Periodic Reports
P3 Health Partners to Participate at Upcoming Investor Conferences
P3 Health Partners Expands to California, Closes Acquisition of Medcore HP and Omni IPA Medical Group, Inc.
P3 Health Partners Announces Participation at the 40th Annual J.P. Morgan Healthcare Conference
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 33.42M
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 319.77M
- P/E
P/E ratio compares a company's share price to its earnings per share.
- —
- P/B
P/B ratio compares a company's share price to its book value per share.
- -0.23
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 0.02
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- -2.29
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 0.22
- EPS
- -37.96
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- —
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- —
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- -85.32M
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- 87.12%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- -18.73%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- -2.15
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 0.33
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 0.33
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.05
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 2.62M
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 10.05
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | 386.39M | 384.81M | 345.25M | 355.79M | 373.23M |
| Gross profit | 50.37M | -41.24M | -24.54M | 4.44M | 1.18M |
| Operating income | 8.24M | -153.87M | -44.22M | -34.12M | -38.09M |
| EBITDA | 29.31M | -132.87M | -23.19M | -13.04M | -17.04M |
| Net income | 1.22M | -75.52M | -31.59M | -20.36M | -20.48M |
| Basic EPS | 0.37 | -23.08 | -9.67 | -6.23 | -6.28 |
| Diluted EPS | 0.32 | -23.08 | -9.67 | -6.23 | -6.28 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 674.16M | 656.64M | 683.56M | 731.59M | 783.87M |
| Total liabilities | 807.32M | 796.88M | 664.64M | 644.41M | 662.79M |
| Total equity | -143.55M | -155.23M | -18.69M | 44.46M | 63.25M |
| Cash & equivalents | 25.5M | 25.01M | 37.71M | 38.58M | 40.08M |
| Current assets | 171.61M | 132.29M | 134.88M | 155.79M | 190.22M |
| Current liabilities | 525.49M | 545.26M | 423.95M | 505M | 506.68M |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | -27.47M | -25.73M | -15.41M | -16.63M | -33.47M |
| Investing cash flow | -43K | 198K | -119K | 50K | — |
| Financing cash flow | 27.81M | 12.87M | 14.67M | 14.62M | 30.66M |
| Change in cash | 295K | -12.66M | -865K | -1.97M | -2.81M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 8-K — P3 Health Partners Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — P3 Health Partners Inc. | View Filing | |
| edgar index | 8-K — P3 Health Partners Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — P3 Health Partners Inc. | View Filing | |
| edgar index | 10-Q — P3 Health Partners Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — Pedersen Leif Elliott | View Filing | |
| edgar index | 8-K — P3 Health Partners Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | PRE 14A — P3 Health Partners Inc. | View Filing | |
| edgar index | S-8 — P3 Health Partners Inc. | View Filing | |
| edgar index | 8-K — P3 Health Partners Inc. | View Filing | |
| edgar index | 10-K — P3 Health Partners Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| ten k section | 10-K — business | View Filing | |
| ten k section | 10-K — mda | View Filing | |
| ten k section | 10-K — risk_factors | View Filing | |
| edgar index | 8-K — P3 Health Partners Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — P3 Health Partners Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4/A — P3 Health Partners Inc. | View Filing | |
| edgar index | 4/A — P3 Health Partners Inc. | View Filing | |
| edgar index | 4/A — P3 Health Partners Inc. | View Filing | |
| edgar index | 4/A — P3 Health Partners Inc. | View Filing | |
| edgar index | 4/A — P3 Health Partners Inc. | View Filing | |
| edgar index | 4/A — P3 Health Partners Inc. | View Filing | |
| edgar index | 4/A — P3 Health Partners Inc. | View Filing | |
| edgar index | 8-K — P3 Health Partners Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — P3 Health Partners Inc. | View Filing | |
| edgar index | 8-K — P3 Health Partners Inc. | View Filing | |
| edgar index | 10-Q — P3 Health Partners Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — P3 Health Partners Inc. | View Filing | |
| edgar index | 8-K — P3 Health Partners Inc. | View Filing | |
| edgar index | 10-Q — P3 Health Partners Inc. | View Filing | |
| edgar index | 4 — P3 Health Partners Inc. | View Filing | |
| edgar index | 4 — P3 Health Partners Inc. | View Filing | |
| edgar index | 4 — P3 Health Partners Inc. | View Filing | |
| edgar index | 4 — P3 Health Partners Inc. | View Filing | |
| edgar index | 4 — P3 Health Partners Inc. | View Filing | |
| edgar index | 4 — P3 Health Partners Inc. | View Filing | |
| edgar index | 4 — P3 Health Partners Inc. | View Filing | |
| form 4 | Form 4 — WASSON GREGORY D | View Filing | |
| form 4 | Form 4 — WASSON GREGORY D | View Filing | |
| form 4 | Form 4 — TOLAN MARY A | View Filing | |
| form 4 | Form 4 — Thierer Mark | View Filing | |
| form 4 | Form 4 — Thierer Mark | View Filing | |
| form 4 | Form 4 — Park Jeffrey G | View Filing | |
| form 4 | Form 4 — Kazarian Gregory N. | View Filing | |
| form 4 | Form 4 — Price Thomas Edmunds | View Filing | |
| form 4 | Form 4 — Leisure Lawrence B. | View Filing | |
| form 4 | Form 4 — Park Jeffrey G | View Filing | |
| form 4 | Form 4 — WASSON GREGORY D | View Filing | |
| form 4 | Form 4 — Thierer Mark | View Filing | |
| form 4 | Form 4 — TOLAN MARY A | View Filing | |
| form 4 | Form 4 — Kazarian Gregory N. | View Filing | |
| form 4 | Form 4 — Price Thomas Edmunds | View Filing | |
| form 4 | Form 4 — Leisure Lawrence B. | View Filing | |
| edgar index | 8-K — P3 Health Partners Inc. | View Filing | |
| edgar index | 8-K — P3 Health Partners Inc. | View Filing | |
| edgar index | SCHEDULE 13D/A — P3 Health Partners Inc. | View Filing | |
| edgar index | 4 — P3 Health Partners Inc. | View Filing | |
| form 4 | Form 4 — Chicago Pacific Founders UGP III, LLC | View Filing | |
| form 4 | Form 4 — Chicago Pacific Founders GP III, L.P. | View Filing | |
| edgar index | 8-K — P3 Health Partners Inc. | View Filing | |
| edgar index | 8-K — P3 Health Partners Inc. | View Filing | |
| edgar index | 10-Q — P3 Health Partners Inc. | View Filing | |
| edgar index | DEF 14A — P3 Health Partners Inc. | View Filing | |
| edgar index | PRE 14A — P3 Health Partners Inc. | View Filing | |
| edgar index | 8-K — P3 Health Partners Inc. | View Filing |